During the past decade, ASU FC S. M. DELLA MISERICORDIA; Oncologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ASU FC S. M. DELLA MISERICORDIA; Oncologia" are "Breast Cancer" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "ASU FC S. M. DELLA MISERICORDIA; Oncologia" in a lesser frequency.

Most popular intervention types in "ASU FC S. M. DELLA MISERICORDIA; Oncologia" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Atezolizumab Matching Placebo" (1 trials), "Ipatasertib" (1 trials), "Paclitaxel" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "ASU FC S. M. DELLA MISERICORDIA; Oncologia" are 3 trials for "All" genders.

Currently, there are NaN active trials in "ASU FC S. M. DELLA MISERICORDIA; Oncologia". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in ASU FC S. M. DELLA MISERICORDIA; Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ASU FC S. M. DELLA MISERICORDIA; Oncologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".